Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Public Policy Evaluation: the Case of the Green Prescription

NCT07234617 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-11-10
Last updated
2025-11-19

Condition(s) studied

Pregnancy

Investigational drug(s) / intervention(s)

Consumption of organic vegetables

Consumption of organic vegetables: Consumption of organic vegetables or non-organic for control group (according to their usual habits) for 2 weeks

Study summary

Numerous studies have highlighted the harmful effects of pesticide exposure during the prenatal period. Food is one of the main vectors of exposure to pesticides, particularly glyphosate, which is the most widely used herbicide. Observational studies have highlighted their effects on health, but few interventional studies have been conducted to identify effective interventions to reduce or eliminate environmental risks. In 2022, the City of Strasbourg implemented the "Ordonnance Verte" (Green Prescription) program, giving all pregnant women in the city access to a weekly basket of organic and local vegetables for several months, as well as awareness-raising workshops on endocrine disruptors and healthy eating. The objective of this study is to assess whether this type of program reduces pregnant women's exposure to pesticides compared to women who continue to eat according to their usual habits. If conclusive, this type of assessment would play a key role in facilitating the rollout of similar initiatives on a larger scale and protecting the health of pregnant women and future children.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Be a woman * Be less than 32 weeks pregnant * Be registered with the "Ordonnance Verte" program * Have agreed, when registering for the program, to be contacted by a research team * Be affiliated with a social security system or be a beneficiary of such a system. * Be fluent in French. * Be over 18 years of age * Be able to understand the objectives and risks associated with the research and give dated and signed informed consent * Have a telephone and internet access Exclusion Criteria: * Participation in a study on nutrition or any other studies likely to affect exposure to the compounds under investigation * Inability to provide informed consent (difficulties in understanding on the part of the pregnant woman, etc.) * Being under judicial protection * Being under guardianship or conservatorship * Working in the agricultural sector (farmer, employee, apprentice) * Living with someone who works in the agricultural sector (farmer, employee, apprentice)

Primary outcome measure(s)

  • Change in urinary pesticide concentrations over the two-week study period in the intervention group — Day 0 and at 2 weeks
    Measured as the difference in pesticide levels before and after the intervention
  • Difference in urinary pesticide concentrations between the two groups — Day 0 and at 2 weeks
    Measured as the difference in pesticide levels in intervention vs. control groups

Trial sites (1)

FacilityCityRegionStatus
Hôpitaux Universitaires de Strasbourg Strasbourg France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07234617 on ClinicalTrials.gov ↗ ← All trials in France